Patient info

C10AB02 bezafibrate

ATC group of level 5 – chemical substance · in plain English: medicines lowering cholesterol, e.g. statins

This site has the patient leaflet or the SPC of 10 medicines in this group.

Active substance: Bezafibrate – all medicines with this substance, also in combinations.

Place in the ATC classification

  1. C Cardiovascular system drugs 1,712 medicines
    1. C10 Lipid modifying agents 208 medicines
      1. C10A Lipid modifying agents, plain 191 medicines
        1. C10AB Fibrates, lipid modifying drugs, plain 29 medicines
          1. C10AB02 bezafibrate 10 medicines

Medicines

MedicineLegal category
Bezafibrate 200 mg film-coated tablets SPC Prescription only (POM)
Bezafibrate Crescent 400 mg prolonged-release tablets SPC Prescription only (POM)
Bezalip Mono Prescription only (POM)
Bezalip Mono 400 mg Prescription only (POM)
Bezalip Mono 400 mg tablets SPC Prescription only (POM)
Bezalip Mono, Calberzol XL 400 mg prolonged-release tablets SPC Prescription only (POM)
Bezalip Retard tablets 400 mg, Bezalip Mono 400 mg tablets SPC no longer supplied –
Bezalip, Bezafibrate 200 mg tablets SPC Prescription only (POM)
Fibrazate XL 400 mg modified release tablets SPC no longer supplied –
Lipozate 400 mg prolonged-release tablets Prescription only (POM)

Other groups of the same level

Other names of the ATC group

Sources

  • Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
  • Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
  • World Health Organization (WHO): ATC/DDD classification, group C10AB02

Contains public sector information licensed under the Open Government Licence v3.0.

Ask your doctor or pharmacist which medicine is right for you.